These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 265663)

  • 1. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes.
    Offner H; Raun NE; Konat G; Fog T; Clausen J
    Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity to viral antigens in multiple sclerosis.
    Zabriskie JB; Espinoza LR; Plank CR; Collins RC
    Acta Neurol Scand Suppl; 1977; 63():239-51. PubMed ID: 265669
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein.
    Wicher V; Olszewski W; Milgrom F
    Clin Exp Immunol; 1979 Jul; 37(1):114-9. PubMed ID: 90569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term transfer-factor treatment for multiple sclerosis.
    Fog T; Pedersen L; Raun NE; Kam-Hansen S; Mellerup E; Platz P; Ryder LP; Jakobsen BK; Grob P
    Lancet; 1978 Apr; 1(8069):851-3. PubMed ID: 76798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte sensitivity to phytohemagglutin (PHA) and pokeweed mitogen (PWM) in patients with multiple sclerosis].
    Czernicki J; Chmielewski H; Jurkowski A
    Pol Tyg Lek; 1974 May; 29(21):881-3. PubMed ID: 4840200
    [No Abstract]   [Full Text] [Related]  

  • 9. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
    Mar P; Gradl T; Dörner C; Contag I
    Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of transfer factors in the treatment of multiple sclerosis: a case report.
    Sacks N; Potgieter HJ; Van Rensburg AJ
    S Afr Med J; 1976 Sep; 50(40):1556-8. PubMed ID: 982209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro lymphocyte transformation of MS patients to paramyxovirus antigens.
    Cunningham-Rundles S; Dupont B; Posner JB; Hansen JA; Good RA
    Acta Neurol Scand Suppl; 1977; 63():145-56. PubMed ID: 192034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocyte transformation test with streptococcal antigens in newborn infants and their mothers].
    Knöll H; Günther M; Estel C; Köhler W
    Zentralbl Gynakol; 1978; 100(11):689-95. PubMed ID: 356489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immunity in multiple sclerosis.
    Platz P
    Acta Neurol Scand Suppl; 1977; 63():133-44. PubMed ID: 300538
    [No Abstract]   [Full Text] [Related]  

  • 14. Spontaneous and PHA stimulated lymphocyte transformation in multiple sclerosis patients during and after acute exacerbations with special reference to steroid therapy.
    Frey H; Molnár G
    Acta Neurol Scand; 1977 Jun; 55(6):443-54. PubMed ID: 878835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of levamisole on cellular immunity in multiple sclerosis.
    Dau PC; Johnson KP; Spitler LE
    Clin Exp Immunol; 1976 Nov; 26(2):302-9. PubMed ID: 991460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in infectious disease, autoimmunity and cancer.
    Spitler LE; Dau PC
    Acta Neurol Scand Suppl; 1977; 63():227-37. PubMed ID: 265668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
    Kateley JR; Bazzell SJ
    Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor.
    Carey JT; Lederman MM; Toossi Z; Edmonds K; Hodder S; Calabrese LH; Proffitt MR; Johnson CE; Ellner JJ
    JAMA; 1987 Feb; 257(5):651-5. PubMed ID: 2432287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.